Key Drivers
- Margin Recovery
- Debt 부담
- Cash Volatility
AIAI Summary
ELAN's Q1 revenue acceleration, raised guidance, and improving margins suggest the turnaround is now becoming a real operating inflection, but the stock still hinges on whether management can translate that momentum into consistent free cash flow and debt reduction before leverage and thin reported profitability reassert pressure.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Recovery
- •Debt 부담
- •Cash Volatility
ELAN is improving operationally with better margins and liquidity, but leverage, intangibles, uneven cash flow, and a rich valuation keep the risk-reward mixed.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Support breakdown
- •Oversold bounce
ELAN has shifted into a bearish short-term downtrend over the last month, breaking $21.4–$21.7 support and remaining vulnerable unless $19.86 holds and price quickly reclaims $21.4–$22.0.
Sharp selloff from $26.18 on 2026-05-06 to $19.86 with lower highs and lower lows
Sentiment & News
Key News Insights:
- •Q1 Beat
- •Guidance Raise
- •Screwworm Approvals
Elanco's strong Q1 beat, raised guidance, and new product approvals point to improving growth momentum and continued balance-sheet progress.
The news is likely supportive for ELAN as stronger execution and product momentum improve near-term outlook and investor confidence
Similar Companies in Healthcare
Other companies in the same sector with AI ratings